Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | Futura Medical PLC - Results for the Year ended 31 December 2024 | 2 | RNS | ||
10.04. | Futura Medical PLC - Notice of Results and Investor Presentation | 5 | RNS | ||
31.03. | Futura Medical PLC - Board Appointment | 4 | RNS | ||
30.01. | AIM WINNERS & LOSERS: Kromek wins deal; Futura Medical warns on profit | 15 | Alliance News | ||
30.01. | Futura Medical PLC - FY24 Trading Update and FY25 Outlook | 9 | RNS | ||
15.01. | Futura Medical PLC - Positive results from WSD4000 Home User study | 9 | RNS | ||
13.01. | Futura Medical PLC - Remuneration of Non-Executive Directors and TVR's | 5 | RNS | ||
15.11.24 | Futura Medical PLC - TR-1: Notification of major holdings | 2 | RNS | ||
FUTURA MEDICAL Aktie jetzt für 0€ handeln | |||||
04.11.24 | Futura Medical reports progress with R&D pipeline | 1 | Sharecast | ||
04.11.24 | Futura Medical progresses study of female sexual dysfunction treatment | 6 | Alliance News | ||
04.11.24 | Futura Medical PLC - Encouraging New Product Development Pipeline | 1 | RNS | ||
31.10.24 | Futura Medical PLC - Total Voting Rights | 1 | RNS |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
NOVO NORDISK | 51,88 | -8,68 % | Novo Nordisk: Überraschende Verkaufsempfehlung | Zur Wochenmitte befindet sich die Aktie von Novo Nordisk erneut auf dem absteigenden Ast. Zur Stunde verliert das Papier gut ein Prozent an Wert. Auf die Stimmung drückt eine Verkaufsempfehlung. Die... ► Artikel lesen | |
GILEAD SCIENCES | 91,99 | +0,08 % | Gilead Sciences: Advancing Oncology Care Through Gilead's Research Scholars Program | NORTHAMPTON, MA / ACCESS Newswire / April 15, 2025 / As a medical oncologist who has practiced in three different countries, Dr. Maria Alice Franzoi is well acquainted with various healthcare systems... ► Artikel lesen | |
AURORA CANNABIS | 3,860 | -1,28 % | Aurora Cannabis Inc (3): Aurora Cannabis offers inhalers to U.K. patients | ||
CANOPY GROWTH | 1,052 | +0,77 % | Canopy Growth: Reverse-Split droht | Die Aktie von Canopy Growth kennt weiterhin nur die Richtung nach unten. Mittlerweile notiert sie sogar unter der 1-Dollar-Marke und ist damit offiziell ein Pennystock. Das ist nicht nur aus Imagesicht... ► Artikel lesen | |
TILRAY BRANDS | 0,400 | +0,78 % | Tilray Brands, Inc.: Tilray Brands Announces Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders | NEW YORK and LEAMINGTON, Ontario, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or "Company") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at... ► Artikel lesen | |
VERTEX PHARMACEUTICALS | 432,00 | +0,48 % | Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? | ||
INNOCAN PHARMA | 0,112 | +2,29 % | InnoCan Pharma Aktie: Kräftige Erholung vom Jahrestief | Der kanadische CBD-Spezialist verzeichnet einen Wochenanstieg von fast 12%, kämpft jedoch weiterhin mit hoher Volatilität und langfristigem Wertverlust im Pharmasektor. Die InnoCan Pharma Aktie verzeichnet... ► Artikel lesen | |
TAAT GLOBAL ALTERNATIVES | 0,138 | +3,38 % | TAAT Global Alternatives Inc (2): TAAT Global has no material changes | ||
CRONOS GROUP | 1,523 | -1,81 % | Cronos Group Inc.: Cronos Appoints Anna Shlimak as Chief Financial Officer | TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company"), an innovative global cannabinoid company, today announced the appointment of Anna... ► Artikel lesen | |
SYNBIOTIC | 3,210 | -3,02 % | EQS-Adhoc: SYNBIOTIC SE: Strategische Partnerschaft mit IRIS Capital Investment | EQS-Ad-hoc: SYNBIOTIC SE / Schlagwort(e): Kapitalmaßnahme/Finanzierung
SYNBIOTIC SE: STRATEGISCHE PARTNERSCHAFT MIT IRIS CAPITAL INVESTMENT
17.04.2025 / 13:21 CET/CEST
Veröffentlichung... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc: Digicann Ventures extends debentures | ||
EYEPOINT PHARMACEUTICALS | 4,778 | -4,25 % | EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., April 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of... ► Artikel lesen | |
EDWARDS LIFESCIENCES | 63,27 | +0,56 % | Edwards Lifesciences Corporation: Edwards SAPIEN M3 Receives CE Mark, Becoming World's First Transfemoral Transcatheter Mitral Valve Replacement System | Edwards Lifesciences Corporation (NYSE: EW) today announced the company's SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic (moderate-to-severe... ► Artikel lesen | |
ORGANIGRAM GLOBAL | 0,916 | +1,33 % | ORGANIGRAM GLOBAL INC. - 6-K, Report of foreign issuer | ||
GREEN THUMB INDUSTRIES | 4,888 | -0,08 % | Green Thumb Industries Reports Fourth Quarter and Full Year 2024 Results | CHICAGO and VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen |